Acromegaly and GH (posters)

SUN 423

Changes of GH Axis after Transsphenoidal Adenomectomy in 1766 Patients with Pituitary Adenoma
Cheol Ryong Ku, Jae Won Hong, Daham Kim, Seunghee Han, Se Hee Park, Young Ki Lee, Sun Ho Kim and Eun Jig Lee

SUN 425

Higher Anabolic Hormone Levels Predict Lower Risk of Worsening Frailty in Men: Prospective Results from the European Male Ageing Study
Agnieszka Swiecicka, Mark Lunt, Tomas Ahern, Terence W. O'Neill, Gyorgy Bartfai, Felipe F Casanueva, Gianni Forti, Aleksander Giwercman, Thang S Han, Krzysztof Kula, Michael E. J. Lean, Neil Pendleton, Margus Punab, Dirk M. Vanderschueren, Ilpo T. Huhtaniemi, Frederick C. W. Wu and Martin K. Rutter

SUN 428

Correlations of Radiographic and Hormonal Indices of Disease Control in a Cohort of Children and Adults with Classic 21-Hydroxylase Deficiency
Adina F. Turcu, Ashwini Mallappa, Meredith Elman, Nilo A Avila, Alexander Tsodikov, Richard J. Auchus and Deborah P. Merke

SUN 429

High-Dose and High-Frequency Lanreotide Autogel in Acromegaly Patients Inadequately Controlled on Conventional Somatostatin Analog Therapy: A Randomized, Open Label, Multicenter Study
Andrea Giustina, Gherardo Mazziotti, Salvatore Cannavo, Roberto Castello, Giorgio Arnaldi, Giovanna Bugari, Renato Cozzi, Diego Ferone, Anna Maria Formenti, Pietro Maffei, Filippo Maffezzoni, Marcella Montini, Massimo Terzolo and Ezio Ghigo

SUN 430

Expert Panel Recommendations for the Management of Patients with Recurrent or Persistent Cushing’s Disease
Eliza B. Geer, Ismat Shafiq, Murray B. Gordon, Vivien Bonert, Alejandro Raul Ayala, Ronald S. Swerdloff, Laurence Katznelson, Ekaterina Manuylova, John D. Carmichael, Vijaya Surampudi, Michael S. Broder, Dasha Cherepanov, Jackie Lee, Qayyim Said, Savita Nandal and Beverly M.K. Biller

SUN 431

Validation of glucagon stimulation test in establishing GH and ACTH deficiency in hypopituitarism and evaluation of AACE/ACE proposed revised cut-point for diagnosis of adult GH deficiency
Shariq Rashid Masoodi, Zhahid Hassan, Mahroosa Ramzan, Raiz A Misgar, Zafar Amin Shah, Mohd Ashraf Ganie and Sridhar Chitturi

SUN 432

Long-Acting Pasireotide Provides Clinical Benefit in Patients with Acromegaly: Results from a 30-Month Analysis of the Phase 3 Paola Study
Mônica R Gadelha, Marcello D Bronstein, Thierry Brue, Laura De Marinis, Maria Fleseriu, Mirtha Guitelman, Gerald Raverot, Ilan Shimon, Juergen Fleck, Pritam Gupta, Alberto M Pedroncelli and Annamaria Colao

SUN 433

The Novel, Ready-to-Use Octreotide Subcutaneous (sc) Depot Provides Higher Exposure and Maintains Response in Patients with Acromegaly and Functioning Neuroendocrine Tumors (NETs) Previously Treated with Long-Acting Octreotide: Results from a Phase 2, Open-Label, Multicenter, Randomized Study
Diego Ferone, Françoise Borson-Chazot, Anne Cailleux, Dieter Hörsch, Harald Lahner, Rosario Pivonello, Libuse Tauchmanova, Christelle Darstein, Håkan Olsson, Fredrik Tiberg and Marianne Pavel

SUN 434

GH Replacement for GH Deficiency after Traumatic Brain Injury Improves Quality of Life, Depressive Symptoms and Metabolic Status, without Improving Axonal Recovery and Cognition
Claire Feeney, David Sharp, Peter J Hellyer, Deborah A Papadopoulou, David Baxter, Sagar Jilka, Timothy Ham, Mark Midwinter and Anthony P. Goldstone

SUN 435

Influence of BMI and Menstrual Cycle on Growth Hormone Nadir Following Oral Glucose Load in Premenopausal Women
Katharina Schilbach, Andreas Lechner, Michael Haenelt, Christina Gar, Rita Schwaiger and Martin Bidlingmaier

SUN 436

Analysis of Japanese Patients with Acromegaly-Classification By Clinical Parameter and mRNA Expressions
Azusa Yamato, Takashi Kohno, Hidekazu Nagano, Kentaro Horiguchi, Naoko Inoshita, Shozo Yamada, Koutaro Yokote and Tomoaki Tanaka

SUN 437

Trabecular Bone Mean Density, but Not Entropy or Uniformity, May Predict Bone Pain in Acromegalic Patients
Armindo Jreige Jr., Olga de Castro Dytz, Arthur Disegna, Rhenan Reis, Vitoria Espindola Leite Borges, Pedro de Azevedo Berger and Luciana Ansaneli Naves

SUN 438

Imaging, Pathological, and Clinical Characteristics of Mixed GH/PRL-Producing Pituitary Adenomas in Patients with Acromegaly: A Large Single Center Experience.
Elena Varlamov, Fabienne Langlois, Joao Prola, Jung Kim, Dawn Shao Ting Lim, Christine G Yedinak, Justin S Cetas and Maria Fleseriu

SUN 439

Treatment Adherence to Pegvisomant (Somavert®) in Spain: PEGASO Study
Rosa Camara, Eva Venegas, Juan Antonio García-Arnés, Fernando Cordido, Javier Aller, Víctor Martín, Laura Sánchez-Cenizo, Nuria Mir and Pegaso study Group

SUN 442

Two-Dimensional Speckle Tracking Echocardiography Demonstrates No Effect of Active Acromegaly on Left Ventricular Strain
Leandro Kasuki, Isabela Volschan, Cintia M. dos Santos Silva, Mônica L. Alcantara, Roberto M. Saraiva, Sérgio Salles Xavier and Mônica R Gadelha

SUN 444

Microvascular Circulation Is Not Altered in Acromegaly
Yalcin Hacioglu, Melike Kalfa, Mutlu Niyazoglu, Hakan Korkmaz, Betul Borku Uysal and Esra Hatipoglu

SUN 445

Prevalence of Symptomatic Cardiopathy in Acromegaly: Experience of a Tertiary Health Center
Vânia Balderrama Brondani, Lara Bessa Campelo Pinheiro Cavalcante, Lygia Leal Freitas de Almendra, Alexandre BC Souza, Felipe HG Duarte, Raquel S Jallad and Marcello D Bronstein

SUN 447

Growth Hormone-Producing Pituitary Adenomas in Childhood or Young Adulthood
Yuichi Nagata, Noriaki Fukuhara, Mitsuo Okada, Hiroshi Nishioka and Shozo Yamada

SUN 448

Evaluation of Acromegaly Symptoms from the Newly Developed Acromegaly Treatment Satisfaction Questionnaire (Acro-TSQ): A Prospective Patient-Reported Outcome Study
Maria Fleseriu, Leon Fogelfeld, Murray B. Gordon, Jill Sisco, William Henry Ludlam, Asi Haviv and Susan D Mathias

SUN 449

Body Mass Index As One of Determinants of Biochemical Control in Acromegaly: 2-Year Data from the Soda Registry
Murray B. Gordon, Mark E Molitch, Whitney W. Woodmansee, Adriana Gabriela Ioachimescu, Olga V. Gambetti, Don Carver, Beloo Mirakhur, David Cox and Roberto Salvatori

SUN 450

Persistent Acromegaly Treatment Patterns and Outcomes
Diane Donegan, Anu Sharma, Nicole M Iniguez Ariza, Frederic Meyer, Jamie Van Gompel, Todd B Nippoldt, John Atkinson and Dana Erickson

SUN 452

Addition of Cabergoline Lowers IGF-I in Acromegaly after Failure of Octreotide-LAR Monotherapy
Arthur Disegna, Armindo Jreige Jr., Rhenan Reis, Vitoria Espindola Leite Borges, Andre Metzker Ferro, Wesley Flavio Lima Jr. and Luciana Ansaneli Naves

SUN 453

3D Volumetric Measurements of Growth Hormone Secreting Adenomas Correlate with Baseline Pituitary Function, Initial Surgery Success Rate and Disease Control
Amit Tirosh, Georgios Papadakis, Prashant Chittiboina, Charalampos Lyssikatos, Elena Belyavskaya, Margaret Farmar Keil, Maya Beth Lodish and Constantine A. Stratakis

SUN 454

SUN 455

Model-Based Predictions of IGF-I Support Once-Weekly Dosing of Somapacitan in Children and Adults
Rasmus Vestergaard Juul, Michael Højby Rasmussen, Henrik Agersø and Rune Viig Overgaard

SUN 456

Alterations in the Hypothalamic-Pituitary-Thyroid Axis Following Growth Hormone Replacement May Attenuate Improvements in Quality of Life
Nigel Glynn, Helena Kenny, Karen McGurren, David Halsall, John H McDermott, Diarmuid Smith, William Tormey, Christopher J Thompson, Donal O'Gorman and Amar Agha

SUN 457

Morphometric Vertebral Fractures in “Difficult” Patients with Acromegaly
Sabrina Chiloiro, Marilda Mormando, Antonella Giampietro, Antonio Bianchi, Domenico Milardi, Anna Maria Formenti, Maria elena Bracaccia, Giuseppe Grande, Chiara Bima, Serena Piacentini, Linda Tartaglione, Alfredo Pontecorvi, Andrea Giustina and Laura De Marinis

SUN 459

Efficiency of Stereotactic Radiotherapy in Acromegaly
Gonca Oruk, Ali Olmezoglu, Melda Apaydin, Nurullah Yuceer and Eyüp Çoban

SUN 461

Homocysteine, Ultrasensitive PCR, Apolipoprotein a-1 and B As Cardiometabolic Risk Markers in Acromegaly Patients
Maria de Fátima Borges, Marília Matos Oliveira, Janaíne Machado Tomé, José Oliveira Ferreira, Maria Cândida Calzada Borges, Mariana Carvalho Garcia, Beatriz Pires Ferreira and Beatriz Hallal Jorge Lara

SUN 462

Retrospective Evaluation of Acromegaly Patients Unresponsive to Treatment with Octreotide-LAR Subsequently Treated with Lanreotide Autogel
Wesley Flavio Lima Jr., Armindo Jreige Jr., Andre Metzker Ferro, Vitoria Espindola Leite Borges, Arthur Disegna, Rhenan Reis and Luciana Ansaneli Naves

SUN 463

Depression Indicators Assessment in Acromegalic Patients
Iago Renato Peixoto, Lia Silvia Kunzler and Luciana Ansaneli Naves

SUN 464

Design and Rationale for the Height Trial, a Phase 3 Transcon GH Study in Children with Growth Hormone Deficiency
Michael Beckert, David Brian Karpf, Eva Mortensen, Jacqueline Mardell, Eva Dam Christoffersen and Jonathan A Leff

SUN 465

Vitamin D Deficiency and PTH Levels in a Cohort of Acromegalic Patients Followed in a Tertiary Center
Paula Paes B Silva, Raquel S Jallad, Clarissa G B Herkenhoff, Felipe H G Duarte, Regina M Martin, Pereira M Rosa and Marcello D Bronstein